Formosa Pharmaceuticals (TPE:6838) Shareholder Yield % : 0.08% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6838 Formosa Pharmaceuticals Inc TPE:6838
48 GF Score
Price NT$23.60
GF Value NT$14.25
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Formosa Pharmaceuticals Shareholder Yield %?

Formosa Pharmaceuticals TPE:6838 -1.67% 48 Shareholder Yield % is 0.08% as of Dec. 2025. GuruFocus rates TPE:6838 with a GF Score™ of 48/100 and a GF Value™ of NT$14.25 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 1,297 Biotechnology companies, Formosa Pharmaceuticals ranks better than 66.85% on this metric.

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return. As of today, Formosa Pharmaceuticals's Shareholder Yield % was 0.08%.


Formosa Pharmaceuticals  (TPE:6838) Shareholder Yield % Explanation

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."

Shareholder Yield % is calculated by three components: Dividend Yield %, Buyback Yield %, and Net Debt Paydown Yield %.

Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.

Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.


Formosa Pharmaceuticals Shareholder Yield % Related Terms


Formosa Pharmaceuticals Shareholder Yield % Historical Data

* Premium members only.

The historical data trend for Formosa Pharmaceuticals's Shareholder Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Formosa Pharmaceuticals Shareholder Yield % Chart

Formosa Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shareholder Yield %
Get a 7-Day Free Trial 0.07 -8.48 -15.36 -11.10 0.07

Formosa Pharmaceuticals Quarterly Data
Dec19 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Shareholder Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.10 0.08 0.08 0.09 0.07

TPE:6838 vs VRTX, REGN, ALNY: Shareholder Yield % Comparison

For the Biotechnology subindustry, Formosa Pharmaceuticals's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Formosa Pharmaceuticals Shareholder Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Formosa Pharmaceuticals's Shareholder Yield % distribution charts can be found below:

* The bar in red indicates where Formosa Pharmaceuticals's Shareholder Yield % falls into.


TPE:6838
48GF Score
Formosa Pharmaceuticals Inc TPE:6838
Shareholder Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Formosa Pharmaceuticals Shareholder Yield % Calculation

Formosa Pharmaceuticals's Shareholder Yield % for the quarter that ended in Dec. 2025 is calculated as:

Shareholder Yield %=Dividend Yield %+Buyback Yield %+Net Debt Paydown Yield %
=0.00 %+0.00 %+0.07 %
=0.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

Frequently Asked Questions Learn more about Shareholder Yield % →
What does a Shareholder Yield % of 0.08% mean?
Formosa Pharmaceuticals (TPE:6838) has a Shareholder Yield % of 0.08% as of Dec. 2025. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Formosa Pharmaceuticals and its competitors. According to the industry distribution chart, Formosa Pharmaceuticals ranks #430 out of 1297 companies in the Biotechnology industry, placing it in the top 33.2%.
Is Formosa Pharmaceuticals' Shareholder Yield % too high?
Formosa Pharmaceuticals' current Shareholder Yield % is 0.08%. Based on the distribution chart, Formosa Pharmaceuticals ranks #430 out of 1297 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Formosa Pharmaceuticals has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Formosa Pharmaceuticals' Shareholder Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Formosa Pharmaceuticals ranks #430 out of 1297 companies for Shareholder Yield %. This puts Formosa Pharmaceuticals in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Biotechnology company?
A good Shareholder Yield % depends on the Biotechnology industry context. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Formosa Pharmaceuticals and its competitors. Formosa Pharmaceuticals's current Shareholder Yield % is 0.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Formosa Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Formosa Pharmaceuticals (TPE:6838) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$14.25, compared to a current price of NT$23.60 — trading 65.6% above its estimated fair value. The current Shareholder Yield % is 0.08%. Formosa Pharmaceuticals' overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Formosa Pharmaceuticals (TPE:6838), the current Shareholder Yield % is 0.08% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Formosa Pharmaceuticals (TPE:6838) Overvalued in 2026?

Based on GuruFocus' analysis, Formosa Pharmaceuticals stock appears to be overvalued. The current stock price of NT$23.60 is trading 65.6% above its estimated GF Value™ of NT$14.25. GuruFocus considers Formosa Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for TPE:6838:

  • Shareholder Yield %: 0.08%
  • GF Value™: NT$14.25 vs. price of NT$23.60 (65.6% above fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the TPE:6838 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Formosa Pharmaceuticals Business Description

Address No. 57, Fuxing North Road, 8th Floor-6, Songshan District, Taipei, TWN, 105
Formosa Pharmaceuticals Inc is engaged in new drug development and transfers. Its Product pipeline includes TSY-110, TSY-120, TSY-310, APP13007 and APP13002.
48GF Score

Get the complete analysis for TPE:6838

Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$23.60
Price
NT$14.25
GF Value